A dedicated committee has been established to “push back” against the current down scheduling plan for CBD amid ongoing fears it will do little to make meaningful medicines more accessible for patients.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The policy group sub-committee on CBD rescheduling has been created by the Medicinal Cannabis Industry Association (MCIA) to ensure the plan does not backfire.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...